A single specimen may need to support patient eligibility, biomarker assessment, pathology review, molecular testing, endpoint evaluation and regulatory submission. Once tissue is consumed, it cannot be replaced. That is why pathology is more than a laboratory service. It is a critical scientific capability that helps transform precious samples into reliable, actionable insights.
At Eurofins Central Laboratory, we help sponsors maximize the value of every tissue sample through specialized pathology expertise, standardized processes and integrated scientific oversight designed to reduce risk, improve data quality and accelerate confident decision-making.
Pathology may represent only one component of a clinical trial, but it can have an outsized impact on success. Decisions involving tissue acquisition, sample handling, interpretation, data standardization and testing strategy can influence the quality of the evidence used throughout development.
Our goal is clear: help sponsors generate the highest possible value from every specimen while delivering consistent pathology data they can trust.
From protocol development through final analysis, we help optimize tissue utilization, prioritize testing strategies and minimize unnecessary consumption. The result is more insight from every specimen and greater confidence in every study decision.
With more than 30 years of experience, our pathology team supports diverse study designs and therapeutic areas. We understand the scientific and operational complexities of tissue-based research and help sponsors anticipate challenges before they affect execution.
Sponsors often need more than pathology review alone. Our coordinated capabilities support histology, cytology, pathology, molecular pathology, global sample logistics, project management and pathology data management within an integrated solution.
Our board-certified pathologists combine deep scientific knowledge with hands-on clinical trial experience to provide accurate, timely and insightful interpretations aligned with study objectives.
In tissue-based research, consistency matters. Variability in sample acquisition, processing, staining, review and reporting can create downstream challenges that affect timelines, endpoints and the usability of clinical trial data.
Through standardized workflows, study-specific review processes, coordinated scientific oversight and structured data management, we help sponsors generate high-quality, decision-ready pathology data with greater confidence.
The value of pathology extends beyond interpretation. We help convert complex observations into structured, analyzable data that supports statistical analysis, regulatory review and strategic decision-making. Standardized terminology, diagnostic codification and data harmonization help reduce ambiguity and improve comparability across samples, sites and studies.
As biomarkers, targeted therapies and precision medicine approaches expand, sponsors need a pathology partner who understands both the science and the operational realities of global clinical development.
Maximize tissue utilization
Improve data consistency
Reduce operational and scientific risk
Support biomarker-driven studies
Accelerate analysis and decision-making
Strengthen confidence in clinical outcomes